Asia-Pacific Sarcopenia Treatment Market - Industry Trends and Forecast to 2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	193 Pages	Data Bridge Market Research	October, 2023	DAABD18360452

Best Price Guarantee
Price	from $3,500
Length	193 Pages
Publisher	Data Bridge Market Research
Published Date	October, 2023
SKU	DAABD18360452

Asia-Pacific Sarcopenia Treatment Market - Industry Trends and Forecast to 2030

The Asia-Pacific sarcopenia treatment market is expected to reach USD 861,882.42 thousand by 2030 from USD 547,450.80 thousand in 2022, growing at a CAGR of 5.9% in the forecast period of 2023 to 2030.
Market Segmentation:
Asia-Pacific Sarcopenia Treatment Market, By Treatment Type (Medications, Vitamin/Dietary Supplements, and Others), Type (Primary Sarcopenia and Secondary Sarcopenia), Stages (Pre-Sarcopenia, Sarcopenia, and Severe Sarcopenia), Route of Administration (Oral, Injectable, and Others), Gender (Male and Female), End User (Hospitals, Specialty Clinics, Home Healthcare, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, New Zealand, Taiwan, and Rest of Asia-Pacific) - Industry Trends and Forecast to 2030
Overview of Asia-Pacific Sarcopenia Treatment Market Dynamics

Driver
• Rising prevalence of sarcopenia

Restrain

• Lack of standardized diagnosis

Opportunity

• Strategic initiatives by key market players

Market Players:

Some of the key market players operating in the Asia-Pacific sarcopenia treatment market are:
• Abbott
• Nestlé Health Science (A subsidiary of Nestlé S.A.)
• Novartis AG
• Sanofi
• AstaReal Co., Ltd.
• Haleon Group of Companies
• BASF SE
• Fermenta Biotech Limited
• Healing Pharma India Pvt.Ltd
• Metagenics
• The Vitamin Company India
• Wellona Pharma
• Biophytis
• ImmunoForge Inc.
• ONCOCROSS CO., LTD.
• OPKO Health, Inc.
• Regeneron Pharmaceuticals Inc.
• DSM

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The Asia-pacific Sarcopenia Treatment Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Dbmr Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Multivariate Modelling; 2.7 Treatment Type Segment Lifeline Curve; 2.8 Market End User Coverage Grid; 2.9 Dbmr Market Position Grid; 2.10 Vendor Share Analysis; 2.11 Secondary Sources; 2.12 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestel-; 4.2 Porter
5 Regulations In Australia
6 Market Overview: 6.1 Drivers; 6.1.1 Rising Prevalence Of Sarcopenia; 6.1.2 Growing Awareness Of Sarcopenia And Its Detrimental Effects On Health; 6.1.3 Lifestyle Factors Such As Poor Nutrition And Sedentary Behaviour; 6.2 Restraints; 6.2.1 Lack Of Standardized Diagnosis; 6.2.2 High Cost Of Treatment And Interventions 50; 6.3 Opportunities; 6.3.1 Strategic Initiatives By Market Players; 6.3.2 Increasing Research And Development Activities; 6.4 Challenges; 6.4.1 Complications Associated With The Sarcopenia Treatment; 6.4.2 Stringent Government Rules And Regulation For Product Approval
7 Asia-pacific Sarcopenia Treatment Market, By Treatment Type: 7.1 Overview; 7.2 Vitamin/Dietary Supplements; 7.2.1 Vitamin Supplements; 7.2.2 Protein Supplements; 7.2.3 Fatty Acid Supplements; 7.2.4 Creatine; 7.2.5 Whey Proteins; 7.2.6 L-carnitine; 7.2.7 Soy; 7.2.8 Beta-alanine; 7.2.9 Ostarine; 7.2.10 Collagen Peptides; 7.2.11 Ligandrol; 7.2.12 Branch-chain Amino Acids; 7.2.13 Hydroxymethylbutyrate (Hmb); 7.2.14 Medium Chain Triglycerides; 7.2.15 Others; 7.3 Medications; 7.3.1 Off Label Drugs; 7.3.2 Emerging Drugs; 7.3.2.1 Ace Inhibitors; 7.3.2.1.1 Appetite Stimulants; 7.3.2.1.2 Oral Antidiabetic Drugs; 7.3.2.1.3 Others; 7.4 Others
8 Asia-pacific Sarcopenia Treatment Market, By Type: 8.1 Overview; 8.2 Primary Sarcopenia; 8.2.1 Vitamin/Dietary Supplements; 8.2.2 Medications; 8.2.3 Others 66; 8.3 Secondary Sarcopenia; 8.3.1 Vitamin/Dietary Supplements; 8.3.2 Medications; 8.3.3 Others
9 Asia-pacific Sarcopenia Treatment Market, By Stages: 9.1 Overview; 9.2 Pre-sarcopenia; 9.3 Sarcopenia; 9.4 Severe Sarcopenia
10 Asia-pacific Sarcopenia Treatment Market, By Route Of Administration: 10.1 Overview; 10.2 Oral; 10.3 Injectables; 10.4 Others
11 Asia-pacific Sarcopenia Treatment Market, By Gender: 11.1 Overview; 11.2 Male; 11.3 Females
12 Asia-pacific Sarcopenia Treatment Market, By End User: 12.1 Overview; 12.2 Hospitals; 12.2.1 Public; 12.2.2 Private; 12.3 Specialty Clinics; 12.4 Home Healthcare; 12.5 Others
13 Asia-pacific Sarcopenia Treatment Market, By Distribution Channel: 13.1 Overview; 13.2 Direct Tender; 13.3 Retail Sales; 13.3.1 Hospital Pharmacies; 13.3.2 Online Pharmacies; 13.3.3 Others; 13.4 Others 90
14 Asia-pacific Sarcopenia Treatment Market, By Countries: 14.1 Asia-pacific; 14.1.1 Japan; 14.1.2 China; 14.1.3 South Korea; 14.1.4 India; 14.1.5 Australia; 14.1.6 Singapore; 14.1.7 Thailand; 14.1.8 Malaysia; 14.1.9 Indonesia; 14.1.10 Philippines; 14.1.11 Vietnam; 14.1.12 New Zealand; 14.1.13 Taiwan; 1.3.1. Rest Of Asia-pacific
15 Asia-pacific Sarcopenia Treatment Market, Company: 15.1 Company Share Analysis: Asia-pacific
16 Swot Analysis
17 Company Profiles: 17.1 Abbott; 17.1.1 Company Snapshot; 17.1.2 Revenue Analysis; 17.1.3 Product Portfolio; 17.1.4 Recent Development; 17.2 Nestlé Health Science (A Subsidiary Of Nestlé S.A.); 17.2.1 Company Snapshot; 17.2.2 Revenue Analysis; 17.2.3 Product Portfolio; 17.2.4 Recent Development; 17.3 Novartis Ag; 17.3.1 Company Snapshot; 17.3.2 Revenue Analysis; 17.3.3 Product Portfolio; 17.3.4 Pipeline Portfolio; 17.3.5 Recent Development 167; 17.4 Sanofi; 17.4.1 Company Snapshot; 17.4.2 Revenue Analysis; 17.4.3 Product Portfolio; 17.4.4 Recent Development; 17.5 Haleon Group Of Companies.; 17.5.1 Company Snapshot; 17.5.2 Revenue Analysis; 17.5.3 Product Portfolio; 17.5.4 Recent Development; 17.6 Astareal Co., Ltd.; 17.6.1 Company Snapshot; 17.6.2 Product Portfolio; 17.6.3 Recent Development; 17.7 Basf Se; 17.7.1 Company Snapshot; 17.7.2 Revenue Analysis; 17.7.3 Product Portfolio; 17.7.4 Recent Development; 17.8 Dsm; 17.8.1 Company Snapshot; 17.8.2 Revenue Analysis; 17.8.3 Product Portfolio; 17.8.4 Recent Development; 17.9 Fermenta Biotech Limited; 17.9.1 Company Snapshot; 17.9.2 Revenue Analysis; 17.9.3 Product Portfolio; 17.9.4 Recent Development; 17.10 Healing Pharma India Pvt.Ind.; 17.10.1 Company Snapshot; 17.10.2 Product Portfolio; 17.10.3 Recent Development; 17.11 Metagenics; 17.11.1 Company Snapshot; 17.11.2 Product Portfolio; 17.11.3 Recent Development; 17.12 The Vitamin Company India; 17.12.1 Company Snapshot; 17.12.2 Product Portfolio; 17.12.3 Recent Development; 17.13 Wellona Pharma; 17.13.1 Company Snapshot; 17.13.2 Product Portfolio; 17.13.3 Recent Development; 17.14 Biophytis; 17.14.1 Company Snapshot; 17.14.2 Pipeline Portfolio; 17.14.3 Recent Development; 17.15 Immunoforge Inc.; 17.15.1 Company Snapshot; 17.15.2 Pipeline Portfolio; 17.15.3 Recent Development; 17.16 Oncocross Co., Ltd.; 17.16.1 Company Snapshot; 17.16.2 Pipeline Portfolio; 17.16.3 Recent Development; 17.17 Opko Health, Inc.; 17.17.1 Company Snapshot; 17.17.2 Revenue Analysis; 17.17.3 Pipeline Portfolio; 17.17.4 Recent Development; 17.18 Regeneron Pharmaceuticals Inc.; 17.18.1 Company Snapshot; 17.18.2 Revenue Analysis; 17.18.3 Pipeline Portfolio; 17.18.4 Recent Development
18 Questionnaire
19 Related Reports
List Of Tables: Table 1 Asia-pacific Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 2 Asia-pacific Vitamin/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 3 Asia-pacific Medicatinons In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 4 Asia-pacific Off-lable Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 5 Asia-pacific Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 6 Asia-pacific Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 7 Asia-pacific Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 8 Asia-pacific Sarcopenia Treatment Market, By Stages , 2021-2030 (Usd Thousand); Table 9 Asia-pacific Sarcopenia Treatment Market, By Route Of Administration , 2021-2030 (Usd Thousand); Table 10 Asia-pacific Sarcopenia Treatment Market, By Gender , 2021-2030 (Usd Thousand); Table 11 Asia-pacific Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 12 Asia-pacific Sarcopenia Treatment Market, By Distribution Channel , 2021-2030 (Usd Thousand); Table 13 Asia-pacific Retail Sales In Sarcopenia Treatment Market, By Distribution Channel , 2021-2030 (Usd Thousand); Table 14 Asia-pacific Sarcopenia Treatment Market, By Country, 2021-2030 (Usd Thousand); Table 15 Japan Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 16 Japan Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 17 Japan Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 18 Japan Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Units); Table 19 Japan Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd In Asp); Table 20 Japan Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 21 Japan Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 22 Japan Primary Sarcopenia In Sarcopeniatreatment Market, By Type, 2021-2030 (Usd Thousand); Table 23 Japan Secondary Sarcopenia In Sarcopeniatreatment Market, By Type, 2021-2030 (Usd Thousand); Table 24 Japan Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand); Table 25 Japan Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 26 Japan Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand); Table 27 Japan Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 28 Japan Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 29 Japan Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 30 Japan Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 31 China Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 32 China Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 33 China Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 34 China Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Units); Table 35 China Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd In Asp); Table 36 China Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 37 China Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 38 China Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 39 China Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 40 China Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand); Table 41 China Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 42 China Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand); Table 43 China Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 44 China Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 45 China Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 46 China Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 47 South Korea Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 48 South Korea Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 49 South Korea Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 50 South Korea Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Units); Table 51 South Korea Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd In Asp); Table 52 South Korea Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 53 South Korea Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 54 South Korea Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 55 South Korea Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 56 South Korea Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand); Table 57 South Korea Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 58 South Korea Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand); Table 59 South Korea Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 60 South Korea Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 61 South Korea Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 62 South Korea Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 63 India Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 64 India Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 65 India Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 66 India Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Units); Table 67 India Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd In Asp); Table 68 India Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 69 India Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 70 India Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 71 India Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 72 India Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand); Table 73 India Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 74 India Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand); Table 75 India Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 76 India Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 77 India Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 78 India Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 79 Australia Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 80 Australia Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 81 Australia Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 82 Australia Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Units); Table 83 Australia Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd In Asp); Table 84 Australia Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 85 Australia Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 86 Australia Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 87 Australia Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 88 Australia Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand); Table 89 Australia Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 90 Australia Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand); Table 91 Australia Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 92 Australia Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 93 Australia Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 94 Australia Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 95 Singapore Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 96 Singapore Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 97 Singapore Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 98 Singapore Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Units); Table 99 Singapore Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd In Asp); Table 100 Singapore Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 101 Singapore Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 102 Singapore Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 103 Singapore Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 104 Singapore Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand); Table 105 Singapore Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 106 Singapore Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand); Table 107 Singapore Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 108 Singapore Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 109 Singapore Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 110 Singapore Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 111 Thailand Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 112 Thailand Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 113 Thailand Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 114 Thailand Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Units); Table 115 Thailand Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd In Asp); Table 116 Thailand Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 117 Thailand Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 118 Thailand Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 119 Thailand Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 120 Thailand Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand); Table 121 Thailand Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 122 Thailand Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand); Table 123 Thailand Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 124 Thailand Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 125 Thailand Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 126 Thailand Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 127 Malaysia Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 128 Malaysia Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 129 Malaysia Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 130 Malaysia Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Units); Table 131 Malaysia Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd In Asp); Table 132 Malaysia Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 133 Malaysia Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 134 Malaysia Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 135 Malaysia Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 136 Malaysia Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand); Table 137 Malaysia Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 138 Malaysia Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand); Table 139 Malaysia Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 140 Malaysia Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 141 Malaysia Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 142 Malaysia Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 143 Indonesia Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 144 Indonesia Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 145 Indonesia Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 146 Indonesia Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Units); Table 147 Indonesia Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd In Asp); Table 148 Indonesia Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 149 Indonesia Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand)
List Of Figures: Figure 1 Asia-pacific Sarcopenia Treatment Market: Segmentation; Figure 2 Asia-pacific Sarcopenia Treatment Market: Data Triangulation; Figure 3 Asia-pacific Sarcopenia Treatment Market: Droc Analysis; Figure 4 Asia-pacific Sarcopenia Treatment Market: Asia-pacific Vs Regional Market Analysis; Figure 5 Asia-pacific Sarcopenia Treatment Market: Company Research Analysis; Figure 6 Asia-pacific Sarcopenia Treatment Market: Interview Demographics; Figure 7 Asia-pacific Sarcopenia Treatment Market: Market End Users Coverage Grid; Figure 8 Asia-pacific Sarcopenia Treatment Market: Dbmr Market Position Grid; Figure 9 Asia-pacific Sarcopenia Treatment Market: Vendor Share Analysis; Figure 10 Asia-pacific Sarcopenia Treatment Market: Segmentation; Figure 11 The Rising Prevalence Of Sarcopenia And Growing Awareness Of Sarcoepnia And Its Detrimental Effect On Health Are Expected To Drive The Growth Of The Asia-pacific Sarcopenia Treatment Market From 2023 To 2030; Figure 12 Vitamin/Dietary Supplements Segment Is Expected To Account For The Largest Share Of The Asia-pacific Sarcopenia Market In 2023 And 2030; Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The Asia-pacific Sarcopenia Treatment Market; Figure 14 Asia-pacific Sarcopenia Treatment Market: By Treatment Type, 2022; Figure 15 Asia-pacific Sarcopenia Treatment Market: By End User, 2023-2030 (Usd Thousand); Figure 16 Asia-pacific Sarcopenia Treatment Market: By Treatment Type, Cagr (2023-2030); Figure 17 Asia-pacific Sarcopenia Treatment Market: By Treatment Type, Lifeline Curve; Figure 18 Asia-pacific Sarcopenia Treatment Market: By Type, 2022; Figure 19 Asia-pacific Sarcopenia Treatment Market: By Type, 2023-2030 (Usd Thousand); Figure 20 Asia-pacific Sarcopenia Treatment Market: By Type, Cagr (2023-2030); Figure 21 Asia-pacific Sarcopenia Treatment Market: By Type, Lifeline Curve; Figure 22 Asia-pacific Sarcopenia Treatment Market: By Stages, 2022; Figure 23 Asia-pacific Sarcopenia Treatment Market: By Stages, 2023-2030 (Usd Thousand); Figure 24 Asia-pacific Sarcopenia Treatment Market: By Stages, Cagr (2023-2030); Figure 25 Asia-pacific Sarcopenia Treatment Market: By Stages, Lifeline Curve; Figure 26 Asia-pacific Sarcopenia Treatment Market: By Route Of Administration, 2022; Figure 27 Asia-pacific Sarcopenia Treatment Market: By Route Of Administration, 2023-2030 (Usd Thousand); Figure 28 Asia-pacific Sarcopenia Treatment Market: By Route Of Administration, Cagr (2023-2030); Figure 29 Asia-pacific Sarcopenia Treatment Market: By Route Of Administration, Lifeline Curve; Figure 30 Asia-pacific Sarcopenia Treatment Market: By Gender, 2022; Figure 31 Asia-pacific Sarcopenia Treatment Market: By Gender, 2023-2030 (Usd Thousand); Figure 32 Asia-pacific Sarcopenia Treatment Market: By Gender, Cagr (2023-2030); Figure 33 Asia-pacific Sarcopenia Treatment Market: By Gender, Lifeline Curve; Figure 34 Asia-pacific Sarcopenia Treatment Market: By End User, 2022; Figure 35 Asia-pacific Sarcopenia Treatment Market: By End User, 2023-2030 (Usd Thousand); Figure 36 Asia-pacific Sarcopenia Treatment Market: By End User, Cagr (2023-2030); Figure 37 Asia-pacific Sarcopenia Treatment Market: By End User, Lifeline Curve; Figure 38 Asia-pacific Sarcopenia Treatment Market: By Distribution Channel, 2022; Figure 39 Asia-pacific Sarcopenia Treatment Market: By Distribution Channel, 2023-2030 (Usd Thousand)